BSPED2014

12 November 2014

09:30-16:00Registration
09:55-16:15CME Training Day - please see separate programme for full information
Please note: the CME Training Day is separate to the BSPED 2014 meeting and there are separate registrations fees to attend each
16:30-18:00 Industry Sponsored Satellite Symposia
Chair(s):S Alvi (Leeds, UK)
Supported by Lilly
16:30 - 17:15Sat Symp 1.1Understanding genetic imprinting
K Temple (Southampton, UK)
17:15 - 18:00Sat Symp 1.2Russell Silver Syndrome: From clinical and molecular diagnosis to treatment
I Netchine (Paris, France)
18:00-19:15Welcome Reception
Guildhall Winchester

13 November 2014

08:00-16:00Registration
08:30-09:00Welcome
Chair(s):J Davies (Southampton, UK)
09:00-10:30Oral Communications 3: Paediatric Endocrinology
Chair(s):T Cheetham (Newcastle, UK) & M Dattani (London, UK)
09:00OC3.1Scottish Audit Of Atypical Genitalia – First Year Results
A Jayasena (Glasgow, UK)
09:10OC3.2Vertebral Fracture Assessment In a Paediatric Population Using Dual-Energy X-ray Absorptiometry.
A Kyriakou (Glasgow, UK)
09:20OC3.3An analysis of meta-data from three UK centres on the sequelae of paediatric craniopharyngiomas over four decades
T Tan (Manchester, UK)
09:30OC3.4Standard Population Screening for Diabetes mellitus has low sensitivity in identifying diabetes in adult survivors of childhood bone marrow transplantation with total body irradiation
C Wei (Bristol, UK)
09:40OC3.5Statistical prediction of HRpQCT microstructural trabecular parameters using 1.5T skeletal MRI
P Dimitri ()
09:50OC3.6A novel non-invasive Short Synacthen Test
C Elder (Sheffield, UK)
10:00OC3.7Patterns of gene expression in pre-pubertal children are associated with the severity of their growth hormone deficiency (GHD)
A Steven (Manchester, UK)
10:10OC3.8Trends In Off-Label Prescription Of Growth Hormone: Results From The National GH Audit
V Saraff (Birmingham, UK)
10:20OC3.9Physiological dose reverse rhythm testosterone treatment abolishes the development of permanent gynaecomastia in adolescents with 47,XXY Klinefelter
G Butler (London, UK)
09:10-09:45Diabetes Professionals session 1
Chair(s):K Beddows (Stockport, UK) & C Gelder (York, UK)
09:10DP1Obesity in Children
N Davis ()
09:45-10:30Diabetes Professionals session 2
Chair(s):K Beddows (Stockport, UK) & C Gelder (York, UK)
09:45DP2Type 2 diabetes
S Etisham (Manchester, UK)
10:30-11:00Tea & Coffee
10:50-11:45Diabetes Professionals session 3
Chair(s):K Beddows (Stockport, UK) & C Gelder (York, UK)
10:50DP3Hypoglycaemia
P Hinsmarsh (London, UK)
11:00-12:30Symposium 1: Controversies in vitamin D deficiency
Chair(s):J Davies (Southampton, UK) & P Arundel (Sheffield, UK)
11:00S1.1Consequences of maternal vitamin D deficiency
C Cooper (Southampton, UK)
11:30S1.2The role of vitamin D deficiency in unexplained fracture of infancy
Z Mughal (Manchester, UK)
12:00S1.3Strategies for prophylaxis and treatment of vitamin D deficiency
N Shaw (Birmingham, UK)
11:45-12:30Diabetes Professionals session 4
Chair(s):K Beddows (Stockport, UK) & C Gelder (York, UK)
11:45DP4Psychology
K Barnard (Southampton, UK)
12:30-14:00RCN CYP AGM
12:30-14:00Lunch, Exhibition and Poster Viewing
13:15-14:00Guided Poster Tour
14:00-14:30Diabetes Professionals session 5
Chair(s):G Parfit (Gwent, UK) & J Summerton (Southampton, UK)
14:00DP5School Care Plans
S Singleton (Blackpool, UK)
14:00-15:00Oral Communications 4: Paediatrtic Endocrinology
Chair(s):J Warner (Cardiff, UK) & N Davis (Southampton, UK)
14:00OC4.1Utility of basal LH in comparison to the GnRH test for identifying central precocious puberty in girls.
E Shepherd (Manchester, UK)
14:06OC4.2Validation of a Food Frequency Questionnaire (FFQ) for rapid assessment of daily dietary Calcium (Ca) intake in children
M Nordblad (Manchester, UK)
14:12OC4.3A role for Delta-like homologue 1 (DLK1) in a secretory placental population and implications for fetal growthgrowthAbstract
M Meso (London, UK)
14:18OC4.4Expression of Sonic hedgehog signalling components in the developing human adrenal cortex.
H Katugampola (London, UK)
14:24OC4.5Adiposity differs by fracture site in children with upper limb fractures
R Moon (Southampton, UK)
14:30OC4.6Evaluating dipeptidyl peptidase-4 expression in patients with diffuse and focal congenital hyperinsulinism.
S Rahman (London, UK)
14:36OC4.7Pitfalls in the diagnosis of neonatal adrenal insufficiency
V Irvine (Southampton, UK)
14:42OC4.8Recombinant Human Growth Hormone (rhGH) In Paediatric Inflammatory Bowel Disease(IBD): Short Term Effects On Bone Biomarkers and Long Term Effects On Bone And Lean Mass
M Altowati (Glasgow, UK)
14:48OC4.9Neurodevelopmental Phenotypes In Children with Early and Late Presenting Congenital Hyperinsulinism (CHI)
Z Mohamed (Hitchin, UK)
14:54OC4.10Impact of prematurity on timing of puberty
E James (Sheffield, UK)
14:30-15:00Diabetes Professionals session 6
Chair(s):G Parfit (Gwent, UK) & J Summerton (Southampton, UK)
14:30DP6Fat and Protein counting what's the evidence?
F Annan (Liverpool, UK)
15:00-15:30Tea & Coffee
15:30-16:30Diabetes Professionals session 7
Chair(s):G Parfit (Gwent, UK) & J Summerton (Southampton, UK)
15:30DP7Best Practice Tariff
F Campbell (Leeds, UK)
15:30-16:30Symposium 2: Recent advances in adrenal disease
Chair(s):N Krone (Birmingham, UK) & L Chan (London, UK)
15:30S2.1Adrenal Development and Adrenal Insufficiency
J Achermann (London, UK)
16:00S2.2Curing Addisson's Disease
S Pearce (Newcastle, UK)
16:45-18:00BSPED AGM
19:30-00:00Conference Dinner and Awards Ceremony
Mercure Winchester Wessex Hotel

14 November 2014

07:30-16:00Registration
08:00-09:00Industry Sponsored Satellite Symposium
Chair(s):C Acerini (Cambridge,UK)
Supported by Ferring Pharmaceuticals
08:00Sat Symp 2.1Maintaining persistence and adherence with subcutaneous growth-hormone therapy in children: comparing Jet delivery and needle-based devices
N Sommerford (Sussex, UK)
08:15sat Symp 2.2Title TBC
J Kirk (Birmingham, UK)
08:30Sat Symp 2.3Patient choice: What does it really mean?
K Davies (London, UK)
08:45Sat Symp 2.4Panel discussion
All speakers ()
09:00-09:55Endocrine Nurse's Business Meeting
Chair(s):A Whitehead (Leeds, UK)
09:00-10:30Symposium 3: New developments from trials in TIDM
Chair(s):P Hindmarsh (London,UK) & F Campbell (Leeds,UK)
09:00S3.1Findings from the DECIDE trial
J Gregory (Cardiff, UK)
09:30S3.2How do the findings from the Hvidore study change practice?
H Hoey (Dublin, Ireland)
10:00S3.3Prevention trials in type 1 diabetes’, including an update on the ongoing TRIGR trial
M Knip (Helsinki, Finland)
09:55-10:00Endocrine Nurse's Welcome
Chair(s):S Kerr (Southampton, UK) & N Nicol (Bristol, UK)
10:00-10:30 Oral Communications 5: Endocrine Nurse session
Chair(s):S Kerr (Southampton, UK) & N Nicol (Bristol,UK)
10:00 - 10:10OC5.1Congenital Adrenal Hyperplasia – a survey on the current practice in U.K
U Niranjan (Sheffield, UK)
10:10 - 10:20OC5.2The impact on families of receiving a diagnosis of congenital hypothyroidism
S Alvi (Leeds, UK)
10:20 - 10:30OC5.3Does treatment with gonadotropin releasing hormone (GnRH) analogues affect BMI in children with precocious or early puberty?
M Madhusudhana (Hull, UK)
10:30-11:00Tea & Coffee
11:00-11:25Endocrine Nurse session 1
Chair(s):S Kerr (Southampton, UK) & N Nicol (Bristol, UK)
EN1Genetics – back to basics
J Williams (Southampton, UK)
11:00-11:30BSPED Research Award Winners Presentation from 2012
PLEASE NOTE: This session has been cancelled due to unforseen circumstances
11:30-11:55Endocrine Nurse session 2
Chair(s):S Kerr (Southampton, UK) & N Nicol (Bristol, UK)
EN2Breathe Easy –the significance of respiratory assessment in Prader-Willi Syndrome
H Evans (Southampton, UK)
11:30-12:30Oral Communications 6: Paediatric Diabetes
Chair(s):J Edge (Oxford, UK) & N Trevelyan (Southampton, UK)
11:30OC6.1Exploring variation in treatment targets across paediatric diabetes units in England and Wales
D Charalampopoulos (London, UK)
11:40OC6.2The diabetic pregnancy and offspring adiposity in infancy and childhood: a meta-analysis
K Logan (London, UK)
11:50OC6.3Comparison of breath acetone, with blood glucose and blood ketones in children and adolescents with type 1 diabetes
J Edge (Oxford, UK)
12:00OC6.4The Role Of The AMP-K Pathway In Mediating The Effects Of Metformin On Mesenchymal Stem Cell Differentiation
S Chen (Glasgow, UK)
12:10OC6.5Withdrawn
12:20OC6.6Comparison of Type 1 diabetic control before and 5 years after transfer to adult services : audit of the 2008 cohort from the Royal Hospital of Sick Children (RHSC), Glasgow
J Wang (Glasgow, UK)
11:55-12:10Endocrine Nurse session 3
Chair(s):S Kerr (Southampton, UK) & N Nicol (Bristol, UK)
EN3Sleep Easy – the practicalities of sleep study
J Dingle-Gavlak (Southampton, UK)
12:15-12:55Endocrine Nurse session 4
Chair(s):S Kerr (Southampton, UK) & A Whitehead (Leeds, UK)
EN4House Discussion: Hydrocortisone In schools - to teach or not to teach
C Davies (Cardiff, UK & R Mayers)
12:30-13:00Oral Communications 7: Paediatric Diabetes
Chair(s):J Edge (Oxford, UK) & N Trevelyan (Southampton, UK)
12:30OC7.1Additional professional support for paediatric patients with diabetes mellitus - are we targeting the right patients?
C Wei (Bristol, UK)
12:36OC7.2Urinary vitamin E metabolites as a biomarker of oxidative stress in type 1 diabetes.
C Bulwer (London, UK)
12:42OC7.3Do diabetes teams give consistent advice on self-management and does it relate to glycaemic control? – Yorkshire and Humber Paediatric Diabetes network survey
U Niranjan (Sheffield, UK)
12:48OC7.4Hyperosmolar hyperglycaemic state –An unusual presentation of type 2 diabetes mellitus in children
P Kalaivanan (London, UK)
12:54OC7.5The relationship of Vibration Perception Threshold with metabolic control and duration of disease in British children with Type 1 Diabetes
J Kallampallil (Manchester, UK)
13:00-14:00Lunch, Exhibition and Poster Viewing
14:00-14:45Plenary guest lecture
Chair(s):J Barton (Bristol, UK)
14:00 -14:45 PL1The future of the child with T1DM
E Gale (Bristol, UK)
14:45-15:45Debate: Children with diabetes should be managed centrally
Chair(s):J Walker (Portsmouth, UK)
14:45D1.2Against
N Hopper (Sunderland, UK)
14:45D1.1For
P Hindmarsh (London, UK)
15:45-16:00Close of meeting